Artificial Intelligence in Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Application, Cancer Type, End Use, and Region

Description

List of Tables

The artificial intelligence (AI) in cancer diagnostics market size is expected to reach USD 2,174.26 million by 2034, according to a new study by Polaris Market Research. The report "Artificial Intelligence in Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Application (Screening & Diagnosis, Tumor Identification, Surveillance, and Treatment), Cancer Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The artificial intelligence in cancer diagnostics market involves the application of AI technologies, including machine learning and deep learning, to enhance the accuracy, efficiency, and speed of cancer detection and diagnosis. AI-powered solutions analyze medical imaging, pathology slides, and genomic data to assist healthcare professionals in identifying cancerous cells and predicting disease progression. The market is experiencing significant growth due to the increasing prevalence of cancer, rising demand for early detection, and advancements in AI-driven imaging and diagnostic tools. Growing adoption of AI in personalized medicine, increasing regulatory approvals, and expanding cloud-based AI solutions are further driving market expansion. The artificial intelligence in cancer diagnostics market opportunities exist in developing AI models for early-stage cancer detection, integrating AI with multi-omics data, and expanding accessibility in emerging markets. As investments in AI-driven healthcare solutions continue to rise, the market is expected to evolve with enhanced capabilities, improved clinical workflows, and greater integration into routine diagnostics.

Artificial Intelligence (AI) in Cancer Diagnostics Market Report Highlights

The screening & diagnosis segment, based on application, held the largest share of the artificial intelligence in cancer diagnostics market revenue in 2024 due to the widespread adoption of AI-driven imaging solutions for early cancer detection. The tumor identification segment is witnessing the fastest growth as AI models improve accuracy in distinguishing malignant and benign tumors.
By cancer type, the breast cancer segment accounted for the largest market share in 2024 due to high global incidence rates and significant AI advancements in mammography. Lung cancer is the fastest-growing segment, driven by increasing demand for AI-powered CT scan analysis and early-stage detection solutions.
North America led the artificial intelligence in cancer diagnostics market share in 2024 due to strong healthcare infrastructure, high AI adoption, and supportive regulatory policies. Asia Pacific is the fastest-growing region, driven by increasing healthcare digitization, rising cancer prevalence, and growing investments in AI-based diagnostics.
Several companies in the market are actively contributing to advancements in early detection and treatment. Microsoft Corporation, IBM Corporation, Siemens Healthineers, GE Healthcare, and Tempus Labs, Inc. are a few notable entities. These organizations are at the forefront of integrating AI into healthcare to enhance diagnostic accuracy and patient outcomes.

Polaris Market Research has segmented the artificial intelligence (AI) in cancer diagnostics market report on the basis of application, cancer type, end use, and region:

By Application Outlook (Revenue - USD Million, 2020-2034)

Screening & Diagnosis
Tumor Identification
Surveillance
Treatment

By Cancer Type Outlook (Revenue - USD Million, 2020-2034)

Breast Cancer
Prostate Cancer
Lung Cancer
Colorectal Cancer
Cervical Cancer
Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals
Diagnostic Centers
Medical Research Institute
Contract Research Organization
Other

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM2592

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Artificial Intelligence in Cancer Diagnostics Market Insights

4.1. Artificial Intelligence in Cancer Diagnostics Market - Market Snapshot
4.2. Artificial Intelligence in Cancer Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Prevalence of Cancer
  - 4.2.1.2. Advancements in AI Algorithms and Imaging Technologies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of standardized protocols
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Artificial Intelligence in Cancer Diagnostics Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Artificial Intelligence in Cancer Diagnostics Market, by Application

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
5.3. Screening & Diagnosis
- 5.3.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Screening & Diagnosis, by Region, 2020-2034 (USD Million)
5.4. Tumor Identification
- 5.4.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Tumor Identification, by Region, 2020-2034 (USD Million)
5.5. Surveillance
- 5.5.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Surveillance, by Region, 2020-2034 (USD Million)
5.6. Treatment
- 5.6.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Treatment, by Region, 2020-2034 (USD Million)

6. Global Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
6.3. Breast Cancer
- 6.3.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Breast Cancer, by Region, 2020-2034 (USD Million)
6.4. Prostate Cancer
- 6.4.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Prostate Cancer, by Region, 2020-2034 (USD Million)
6.5. Lung Cancer
- 6.5.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Lung Cancer, by Region, 2020-2034 (USD Million)
6.6. Colorectal Cancer
- 6.6.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Colorectal Cancer, by Region, 2020-2034 (USD Million)
6.7. Cervical Cancer
- 6.7.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Cervical Cancer, by Region, 2020-2034 (USD Million)
6.8. Others
- 6.8.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Artificial Intelligence in Cancer Diagnostics Market, by End-Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
7.3. Hospitals
- 7.3.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Hospitals, by Region, 2020-2034 (USD Million)
7.4. Diagnostic Centers
- 7.4.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Diagnostic Centers, by Region, 2020-2034 (USD Million)
7.5. Medical Research Institute
- 7.5.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Medical Research Institute, by Region, 2020-2034 (USD Million)
7.6. Contract Research Organization
- 7.6.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Contract Research Organization, by Region, 2020-2034 (USD Million)
7.7. Other
- 7.7.1. Global Artificial Intelligence in Cancer Diagnostics Market, by Other, by Region, 2020-2034 (USD Million)

8. Global Artificial Intelligence in Cancer Diagnostics Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Artificial Intelligence in Cancer Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Artificial Intelligence in Cancer Diagnostics Market - North America
- 8.3.1. North America: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
- 8.3.2. North America: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
- 8.3.3. North America: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.3.4. Artificial Intelligence in Cancer Diagnostics Market - U.S.
  - 8.3.4.1. U.S.: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.3.5. Artificial Intelligence in Cancer Diagnostics Market - Canada
  - 8.3.5.1. Canada: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
8.4. Artificial Intelligence in Cancer Diagnostics Market - Europe
- 8.4.1. Europe: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
- 8.4.2. Europe: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
- 8.4.3. Europe: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.4.4. Artificial Intelligence in Cancer Diagnostics Market - UK
  - 8.4.4.1. UK: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.4.5. Artificial Intelligence in Cancer Diagnostics Market - France
  - 8.4.5.1. France: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.4.5.2. France: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.4.5.3. France: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.4.6. Artificial Intelligence in Cancer Diagnostics Market - Germany
  - 8.4.6.1. Germany: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.4.7. Artificial Intelligence in Cancer Diagnostics Market - Italy
  - 8.4.7.1. Italy: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.4.8. Artificial Intelligence in Cancer Diagnostics Market - Spain
  - 8.4.8.1. Spain: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.4.9. Artificial Intelligence in Cancer Diagnostics Market - Netherlands
  - 8.4.9.1. Netherlands: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.4.10. Artificial Intelligence in Cancer Diagnostics Market - Russia
  - 8.4.10.1. Russia: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.4.11. Artificial Intelligence in Cancer Diagnostics Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
8.5. Artificial Intelligence in Cancer Diagnostics Market - Asia Pacific
- 8.5.1. Asia Pacific: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.5.4. Artificial Intelligence in Cancer Diagnostics Market - China
  - 8.5.4.1. China: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.5.4.2. China: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.5.4.3. China: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.5.5. Artificial Intelligence in Cancer Diagnostics Market - India
  - 8.5.5.1. India: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.5.5.2. India: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.5.5.3. India: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.5.6. Artificial Intelligence in Cancer Diagnostics Market - Malaysia
  - 8.5.6.1. Malaysia: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.5.7. Artificial Intelligence in Cancer Diagnostics Market - Japan
  - 8.5.7.1. Japan: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.5.8. Artificial Intelligence in Cancer Diagnostics Market - Indonesia
  - 8.5.8.1. Indonesia: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.5.9. Artificial Intelligence in Cancer Diagnostics Market - South Korea
  - 8.5.9.1. South Korea: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.5.10. Artificial Intelligence in Cancer Diagnostics Market - Australia
  - 8.5.10.1. Australia: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.5.11. Artificial Intelligence in Cancer Diagnostics Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
8.6. Artificial Intelligence in Cancer Diagnostics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.6.4. Artificial Intelligence in Cancer Diagnostics Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.6.5. Artificial Intelligence in Cancer Diagnostics Market - UAE
  - 8.6.5.1. UAE: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.6.6. Artificial Intelligence in Cancer Diagnostics Market - Israel
  - 8.6.6.1. Israel: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.6.7. Artificial Intelligence in Cancer Diagnostics Market - South Africa
  - 8.6.7.1. South Africa: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.6.8. Artificial Intelligence in Cancer Diagnostics Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
8.7. Artificial Intelligence in Cancer Diagnostics Market - Latin America
- 8.7.1. Latin America: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
- 8.7.2. Latin America: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
- 8.7.3. Latin America: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.7.4. Artificial Intelligence in Cancer Diagnostics Market - Mexico
  - 8.7.4.1. Mexico: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.7.5. Artificial Intelligence in Cancer Diagnostics Market - Brazil
  - 8.7.5.1. Brazil: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.7.6. Artificial Intelligence in Cancer Diagnostics Market - Argentina
  - 8.7.6.1. Argentina: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)
- 8.7.7. Artificial Intelligence in Cancer Diagnostics Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Artificial Intelligence in Cancer Diagnostics Market, by Application, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Artificial Intelligence in Cancer Diagnostics Market, by Cancer Type, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Artificial Intelligence in Cancer Diagnostics Market, by End-Use, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Aidoc Medical Ltd.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Flatiron Health, Inc. (A subsidiary of Roche)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. GE Healthcare Technologies Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Guardant Health, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. IBM Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Kheiron Medical Technologies Limited
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Microsoft Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Paige.AI, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. PathAI, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Siemens Healthineers AG
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development